↓ Skip to main content

American Association for Cancer Research

BRAFV600E: Implications for Carcinogenesis and Molecular Therapy

Overview of attention for article published in Molecular Cancer Therapeutics, March 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
patent
5 patents

Citations

dimensions_citation
366 Dimensions

Readers on

mendeley
439 Mendeley
Title
BRAFV600E: Implications for Carcinogenesis and Molecular Therapy
Published in
Molecular Cancer Therapeutics, March 2011
DOI 10.1158/1535-7163.mct-10-0799
Pubmed ID
Authors

Emma R Cantwell-Dorris, John J O'Leary, Orla M Sheils

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 439 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 3 <1%
United Kingdom 2 <1%
South Africa 1 <1%
India 1 <1%
Brazil 1 <1%
Germany 1 <1%
Denmark 1 <1%
Spain 1 <1%
United States 1 <1%
Other 0 0%
Unknown 427 97%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 78 18%
Student > Ph. D. Student 74 17%
Researcher 68 15%
Student > Master 50 11%
Other 26 6%
Other 67 15%
Unknown 76 17%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 101 23%
Medicine and Dentistry 99 23%
Agricultural and Biological Sciences 99 23%
Immunology and Microbiology 14 3%
Chemistry 11 3%
Other 33 8%
Unknown 82 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 19. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 September 2023.
All research outputs
#2,017,064
of 25,837,817 outputs
Outputs from Molecular Cancer Therapeutics
#211
of 4,105 outputs
Outputs of similar age
#8,199
of 123,599 outputs
Outputs of similar age from Molecular Cancer Therapeutics
#1
of 25 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,105 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.9. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 123,599 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 25 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.